orforglipron

Foundayo: UAE Approves First Oral Obesity Pill

The UAE approved Foundayo, Eli Lilly's oral obesity pill (orforglipron), on 3 April 2026 — two days after FDA approval. Abu Dhabi's Department of Health added it to its Personalised Weight Management Programme, making the UAE the second country in the world to offer this

28 Apr 2026